Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-13,920
Closed -$750K 168
2016
Q3
$750K Hold
13,920
0.09% 101
2016
Q2
$754K Sell
13,920
-400
-3% -$21.1K 0.09% 98
2016
Q1
$726K Hold
14,320
0.08% 106
2015
Q4
$722K Buy
14,320
+160
+1% +$8.15K 0.08% 111
2015
Q3
$681K Hold
14,160
0.08% 111
2015
Q2
$737K Sell
14,160
-360
-2% -$20.3K 0.07% 120
2015
Q1
$838K Buy
14,520
+360
+3% +$20.6K 0.08% 112
2014
Q4
$756K Sell
14,160
-15,080
-52% -$844K 0.06% 117
2014
Q3
$1.68M Hold
29,240
0.16% 83
2014
Q2
$1.96M Sell
29,240
-58
-0.2% -$3.93K 0.17% 83
2014
Q1
$1.96M Hold
29,298
0.18% 77
2013
Q4
$1.96M Buy
29,298
+9,440
+48% +$612K 0.18% 80
2013
Q3
$1.25M Buy
+19,858
New +$1.28M 0.13% 87

Other funds holding GSK

Beach Investment Counsel's GSK Position: Q4 2016 in Review

Beach Investment Counsel sold out of GSK (GSK) in Q4 2016, closing a stake of 13,920 shares — an estimated $750K sold.

Beach Investment Counsel first reported a position in GSK in Q3 2013 and held it in 13 quarters. The position peaked at $1.96M in Q1 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Beach Investment Counsel reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Beach Investment Counsel sold 13,920 GSK shares in Q4 2016, an estimated $750K.
  • Beach Investment Counsel first reported a position in GSK in Q3 2013 and held it in 13 quarters.
  • Beach Investment Counsel's GSK position peaked at $1.96M in Q1 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Beach Investment Counsel's 13F filing for Q4 2016, filed 10 Feb 2017.